Recombinant multi-species IDO1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IDO1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes indoleamine 2,3-dioxygenase (IDO) - a heme enzyme that catalyzes the first and rate-limiting step in tryptophan catabolism to N-formyl-kynurenine. This enzyme acts on multiple tryptophan substrates including D-tryptophan, L-tryptophan, 5-hydroxy-tryptophan, tryptamine, and serotonin. This enzyme is thought to play a role in a variety of pathophysiological processes such as antimicrobial and antitumor defense, neuropathology, immunoregulation, and antioxidant activity. Through its expression in dendritic cells, monocytes, and macrophages this enzyme modulates T-cell behavior by its peri-cellular catabolization of the essential amino acid tryptophan.[provided by RefSeq, Feb 2011]
The Alternative Names of target: 3-dioxygenase,3-dioxygenase 1,IDO,IDO-1,IDO1,INDO,Ido,Ido1,Indo,Indoleamine 2,Indoleamine-pyrrole 2

Target products collectionGo to IDO1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T89697-Ag-1/ GM-Tg-hg-T89697-Ag-2 Human IDO1 protein Human
GM-Tg-rg-T89697-Ag-1/ GM-Tg-rg-T89697-Ag-2 Rat IDO1 protein Rat
GM-Tg-mg-T89697-Ag-1/ GM-Tg-mg-T89697-Ag-2 Mouse IDO1 protein Mouse
GM-Tg-cynog-T89697-Ag-1/ GM-Tg-cynog-T89697-Ag-2 Cynomolgus/Rhesus macaque IDO1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T89697-Ag-1/ GM-Tg-felg-T89697-Ag-2 Feline IDO1 protein Feline
GM-Tg-cang-T89697-Ag-1/ GM-Tg-cang-T89697-Ag-2 Canine IDO1 protein Canine
GM-Tg-bovg-T89697-Ag-1/ GM-Tg-bovg-T89697-Ag-2 Bovine IDO1 protein Bovine
GM-Tg-equg-T89697-Ag-1/ GM-Tg-equg-T89697-Ag-2 Equine IDO1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T89697-Ag-1/ GM-Tg-hg-T89697-Ag-2; GM-Tg-rg-T89697-Ag-1/ GM-Tg-rg-T89697-Ag-2;
GM-Tg-mg-T89697-Ag-1/ GM-Tg-mg-T89697-Ag-2; GM-Tg-cynog-T89697-Ag-1/ GM-Tg-cynog-T89697-Ag-2;
GM-Tg-felg-T89697-Ag-1/ GM-Tg-felg-T89697-Ag-2; GM-Tg-cang-T89697-Ag-1/ GM-Tg-cang-T89697-Ag-2;
GM-Tg-bovg-T89697-Ag-1/ GM-Tg-bovg-T89697-Ag-2; GM-Tg-equg-T89697-Ag-1/ GM-Tg-equg-T89697-Ag-2
Products Name IDO1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name IDO1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IDO1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.